Research study for people with Type 1 Diabetes: EXALT

Recruitment Closed



The main purpose of this study is to assess the safety of three different doses of an investigational drug in patients who have been recently diagnosed with type 1 diabetes.

The investigational drug is a “therapeutic vaccine” and affects the body’s immune system response to a medical condition or disease. It is designed to stop the immune system from attacking cells that produce insulin, which may help insulin production in patients with recently diagnosed type 1 diabetes.

In this study, patients will receive 4 injections of the investigational drug over a period of 6 weeks. Total study participation will last approximately 24 weeks, which includes 8 study clinic visits for various tests and evaluations.

All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related time and travel may be provided.

To pre-qualify for this study, you must:

  • Be 18 to 30 years of age
  • Have been diagnosed with type 1 diabetes in the last 6 months
  • Have an insulin requirement

If you are interested in taking part please complete the Getting Involved form.